The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland
A primary investment of Rs 194.4 crore has been made
Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity
Leading this effort was Cytel’s principal research scientist and Professor of Health Research Methods at McMaster University in Canada, Dr. Edward Mills
This new fund is amongst the largest for the sector in India
Quantib Prostate is an AI-based software solution that advances the MRI prostate reporting workflow and is accessible directly from the radiologist's reading station
WHO and UNICEF call on governments, industry, donors and civil society to fund and prioritize access to assistive products
Q1 net sales increased by 12.2% to € 5,198 million compared with the year-earlier quarter
Company's net income rose by 57.5 percent to 3.291 billion euros in Q1
The partners also aim to expand their work to Latin America for the first time
Subscribe To Our Newsletter & Stay Updated
